Last reviewed · How we verify
NCT06580639: MGIA
The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
trial testing No intervention. in Tuberculosis in 280 participants. Currently enrolling.
1 March 2025
Quick facts
| Lead sponsor | Linkoeping University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 280 |
| Start date | 1 August 2020 |
| Primary completion | 1 March 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 2 locations across Sweden |
Drugs / interventions tested
- No intervention.
Conditions studied
- Tuberculosis — all drugs for Tuberculosis →
- Immunologic Activity Alteration — all drugs for Immunologic Activity Alteration →
Sponsor
Linkoeping University
Who can join
18 and older, any sex, with Tuberculosis or Immunologic Activity Alteration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to learn about how the blood leucocytes from patients with and without exposure or disease from tuberculosis (TB) are able to kill live mycobacteria (M. tuberculosis). The main question it aims to answer is: Is intracellular growth suppression of M. tuberculosis in peripheral blood mononuclear cells variable among healthy blood donors and higher than in patients with latent TB compared to active TB?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06580639
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention.
Trials testing the same drug.
- NCT06843863 — The Effects of Smartphone Addiction on Pinch Strength, Muscle Stiffness, and Hand/Wrist Function in Young Adults · recruiting
- NCT07084883 — Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneratio · recruiting
- NCT06427018 — Expressions of Ezrin and Pip5k1α Proteins in Airway Smooth Muscle of Asthmatic Patients · recruiting
- NCT06134739 — Arterial Embolism After Catheter Ablation of Atrial Fibrillation. ATRIAL FIBRILLATION · unknown
- NCT05963126 — Fetuin A as a Predictor of Deterioration of Renal Function in Hypertonic Patients · recruiting
Other recruiting trials for Tuberculosis
Currently open trials in the same condition.
- NCT05917210 — Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda · NA · recruiting
- NCT07170735 — Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level · recruiting
- NCT07484490 — Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis · NA · recruiting
- NCT06318416 — Precision Rifampin Trial for Personalized Dosing · Phase 1 · recruiting
- NCT07170800 — A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets · Phase 2 · recruiting
Other Linkoeping University trials
Trials by the same sponsor.
- NCT07494422 — A Path to Prevention of Elder Abuse in Long-term Care. Prevalence Study Among Staff in Long-term Care. · not yet recruiting
- NCT07485439 — Self-inspired & Tailored Autism Movement With Phystic App · NA · enrolling by invitation
- NCT07391540 — ICBT for Psychological Symptoms Related to Economy · NA · recruiting
- NCT07181213 — Genetic Predisposition to High Blood Pressure · NA · enrolling by invitation
- NCT07312136 — MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06580639 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Linkoeping University
- Last refreshed: 30 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06580639.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing